Skip navigation
Speakers

The World’s Largest and Highest Acclaimed Life Sciences Event for CFOs, Controllers and Finance Executives

March 19-21, 2018
  • Philadelphia, PA

Cindy Anderson
Senior Director, Financial Reporting
Alexion Pharmaceuticals

Robert Auslander
Vice President Technical Accounting and Policy
Valeant Pharmaceuticals

William “Chip” Baird
Chief Financial Officer
Amicus Therapeutics

Charles A. Bancroft
Executive Vice President and Chief Financial Officer
Bristol-Myers Squibb

Lisa Banker
Partner / Principal
Northeast Life Sciences Transactions Market Leader
Ernst & Young LLP

Melissa Bird
Senior Manager, Financial Advisory Services
Ernst & Young LLP

Thomas Bogle
Director, Advisory Services
PwC

Larry Breen
Director, Financial Planning and Analysis / Revenue Analytics
Sunovion Phamaceuticals

Michael Briganti
Director, Business Controls Function Lead
International Risk Management
Bristol-Myers Squibb

Winna Brown
Partner, Boston FAAS Life Sciences Leader
Ernst & Young LLP

Matthew Busch
Director, Technical Accounting and External Reporting
Amgen

Brian Cahill
Corporate Controller
Eagle Pharmaceuticals, Inc.

Justin Calvert, CFA, CPA
Director, Global Banking & Markets
Bank of America Merrill Lynch

Rick Capasso
Executive Director
Ernst and Young LLP

Rhonda Chicko
Chief Financial Officer
Editas Medicine

Andreas Chrysostomou
Managing Director
Duff & Phelps

Chad Cohen
Chief Financial Officer
Adaptive Biotechnologies

Gina Consylman
Senior Vice President and Chief Financial Officer
Ironwood Pharmaceuticals

Chris Cooper
US Audit & Assurance Life, Sciences & Health Care Leader
Deloitte & Touche LLP

James D’Arreca
Chief Accounting Officer
Allergan PLC

Christine Davine
Deputy Managing Partner
Deloitte & Touche LLP

Lynn DeHart
Senior Director, Business Technology Finance Expert Functions
Pfizer Inc

Angela DeVito
Executive Director, Head of Global Business Controls
Bristol-Myers Squibb

Mark Drozdowski
Partner, Life Sciences — National Audit Leader
KPMG LLP

Dan Durham
Executive Vice President, Health Policy
BIO

Michael Ehret
Vice President, Human Resources
Medical Devices Commercial Franchises
Johnson & Johnson

Jeff Ellis
Partner, Life Sciences Professional Practice Director
Deloitte & Touche LLP

Cathy Engelbert
Chief Executive Officer
Deloitte

Matt Eyles
America’s Health Insurance Plans (AHIP)

David Friend, MD, MBA
Managing Director and Chief Transformation Officer
BDO Center for Healthcare Excellence & Innovation

Nalneesh Gaur
Partner
PwC

Jeremy Gelber
Partner
Pamplona Capital

David Gollaher
Vice President, Government Affairs and Policy
Gilead Sciences

Tim Gordon
Global FAAS Life Sciences Leader
Ernst & Young LLP

David Green
Managing Partner, Life Sciences
Deloitte Tax LLP

Mark Guerin
Chief Financial Officer
Onconova

Shanti Gupta
Partner, Financial Accounting Advisory Services
Ernst & Young LLP

Mark Hanulak
Senior Manager, Audit Services
Deloitte & Touche LLP

Rich Holtz
Senior Manager, Audit Services
Deloitte & Touche LLP

Dennis Howell
Partner, Life Sciences Professional Practice Deputy Director
Deloitte & Touche LLP

Marsha L. Hunt
Board Member
FASB

Glenn Hunzinger
Life Science Deals Leader
PwC

Andrew Jennings
Corporate Controller
Egalet

Brian Jobe
Partner
Deloitte & Touche LLP

Timothy Kocses
Director, Corporate Technical Accounting
Bristol-Myers Squibb

David Lansky, PhD
President and CEO
Pacific Business Group on Health

Peter Licata
Chief Financial Officer
Edenbridge Pharmaceuticals, LLC

Mike Lombardo
Partner
Deloitte & Touche LLP

Kevin MacKay
Vice President, Global Technical Accounting
Advisory Services and Policies
Pfizer Inc

Mike Makovec
Audit Senior Manager
Deloitte & Touche LLP

Sal Mannarino
Senior Manager, Transaction Advisory Services
Ernst & Young LLP

Mark Merritt
President and CEO
PCMA

Peter J. Micca
US Audit & Assurance Health Tech Leader
Deloitte & Touche LLP

Jeffrey Miller
Senior Director, Commercial Operations Revenue Management
Impax Laboratories

Alasdair Milton, PhD
Vice President, Life Sciences — Parthenon
Ernst & Young LLP

Karim Munir
Director, Consolidations and Financial Reporting
Bristol-Myers Squibb

Federica “Freddi” O’Brien
Chief Financial Officer
Cerecor

Robert Owens
Vice President and Head of Accounting
Bristol-Myers Squibb

Frank Panaro
Director, Finance Gross to Net
Purdue Pharma L.P.

Christopher Park
Partner
Deloitte & Touche LLP

Sunil Patel
Vice President and Head of Corporate Development
Merck

Patrick D. Pilch, CPA, MBA
Managing Director and National Healthcare Leader
BDO Center for Healthcare Excellence & Innovation

Michael Pine
Vice President, Corporate Development and Licensing
Aralez Pharma

Graham Poles
Partner
PwC

Jim Quinlan
Partner
CFGI

Ravi Raghunathan, CPA
Partner - Life Sciences Industry Leader
CohnReznick LLP

Bryan Reasons
Chief Financial Officer
Impax Labs

Joe Reilly
Executive Director and Controller USP
Bristol-Myers Squibb

Derek Riesenberg
Vice President, Life Sciences — Parthenon
Ernst & Young LLP

Stephen Rivera
Vice President, Global Technical Accounting Advisory Services & Policy
Johnson & Johnson

William Roberts
Partner
Ernst & Young LLP

Laura Robinette
U.S. Pharmaceutical and Life Sciences Assurance Leader
PwC

James Rosenberg
Senior Assistant Chief Accountant, Office of Health Care and Insurance
U.S. Securities & Exchange Commission

Jessica Alysse Rubin, CPA
Executive Director, Finance and Assistant Controller
Acorda Therapeutics

Francis Ruffy
Director, Advisory Services
PwC

Bruce Rucks
Partner
Deloitte & Touche LLP

Maya Said, ScD
Founder and CEO
Outcomes4Me

Chris Santucci
Director
PwC

Brad Schulte
Senior Manager
Deloitte & Touche LLP

Jennifer Sharpe
Senior Director, Revenue Analytics Collaborative
daVIZta Inc., a Revenue Analytics Company

Michael Shultz
Director, Finance Transformation
BlackLine

Leigh Anne Siino
Director, Consulting Services
CGI

Robert P. Silvers
Partner, Litigation Department
Paul Hastings

Tedd Smith
Managing Director — Investment Banking
Morgan Stanley

Julie Song
Vice President, Chief Compliance Officer,
Ethics and Compliance Office
IQVIA

Corey Sparks
Executive Director, Controller & SBLO
Eisai Inc.

Nancy Stempin
Executive Director, Financial Accounting Advisory Services
Ernst & Young LLP

Jeffrey Stoll, PhD
Managing Director, Life Sciences – Parthenon
Ernst & Young LLP

Sagar Teotia
Deputy Chief Accountant
U.S. Securities & Exchange Commission

Erica Vandell
Director
The Siegfried Group, LLP

Scott Walters
Partner, Transaction Tax
Ernst & Young LLP

Michael Webster
Director, Technology & Management Consulting
RSM US LLP

Zachary Weisbly
Senior Manager
PwC

Walt Worsham
Senior Manager
Deloitte & Touche LLP

Cindy Anderson
Senior Director, Financial Reporting
Alexion Pharmaceuticals

Robert Auslander
Vice President Technical Accounting and Policy
Valeant Pharmaceuticals

William “Chip” Baird
Chief Financial Officer
Amicus Therapeutics

Charles A. Bancroft
Executive Vice President and Chief Financial Officer
Bristol-Myers Squibb

Lisa Banker
Partner / Principal
Northeast Life Sciences Transactions Market Leader
Ernst & Young LLP

Melissa Bird
Senior Manager, Financial Advisory Services
Ernst & Young LLP

Thomas Bogle
Director, Advisory Services
PwC

Larry Breen
Director, Financial Planning and Analysis / Revenue Analytics
Sunovion Phamaceuticals

Michael Briganti
Director, Business Controls Function Lead
International Risk Management
Bristol-Myers Squibb

Winna Brown
Partner, Boston FAAS Life Sciences Leader
Ernst & Young LLP

Matthew Busch
Director, Technical Accounting and External Reporting
Amgen

Brian Cahill
Corporate Controller
Eagle Pharmaceuticals, Inc.

Justin Calvert, CFA, CPA
Director, Global Banking & Markets
Bank of America Merrill Lynch

Rick Capasso
Executive Director
Ernst and Young LLP

Rhonda Chicko
Chief Financial Officer
Editas Medicine

Andreas Chrysostomou
Managing Director
Duff & Phelps

Chad Cohen
Chief Financial Officer
Adaptive Biotechnologies

Gina Consylman
Senior Vice President and Chief Financial Officer
Ironwood Pharmaceuticals

Chris Cooper
US Audit & Assurance Life, Sciences & Health Care Leader
Deloitte & Touche LLP

James D’Arreca
Chief Accounting Officer
Allergan PLC

Christine Davine
Deputy Managing Partner
Deloitte & Touche LLP

Lynn DeHart
Senior Director, Business Technology Finance Expert Functions
Pfizer Inc

Angela DeVito
Executive Director, Head of Global Business Controls
Bristol-Myers Squibb

Mark Drozdowski
Partner, Life Sciences — National Audit Leader
KPMG LLP

Dan Durham
Executive Vice President, Health Policy
BIO

Michael Ehret
Vice President, Human Resources
Medical Devices Commercial Franchises
Johnson & Johnson

Jeff Ellis
Partner, Life Sciences Professional Practice Director
Deloitte & Touche LLP

Cathy Engelbert
Chief Executive Officer
Deloitte

Matt Eyles
America’s Health Insurance Plans (AHIP)

David Friend, MD, MBA
Managing Director and Chief Transformation Officer
BDO Center for Healthcare Excellence & Innovation

Nalneesh Gaur
Partner
PwC

Jeremy Gelber
Partner
Pamplona Capital

David Gollaher
Vice President, Government Affairs and Policy
Gilead Sciences

Tim Gordon
Global FAAS Life Sciences Leader
Ernst & Young LLP

David Green
Managing Partner, Life Sciences
Deloitte Tax LLP

Mark Guerin
Chief Financial Officer
Onconova

Shanti Gupta
Partner, Financial Accounting Advisory Services
Ernst & Young LLP

Mark Hanulak
Senior Manager, Audit Services
Deloitte & Touche LLP

Rich Holtz
Senior Manager, Audit Services
Deloitte & Touche LLP

Dennis Howell
Partner, Life Sciences Professional Practice Deputy Director
Deloitte & Touche LLP

Marsha L. Hunt
Board Member
FASB

Glenn Hunzinger
Life Science Deals Leader
PwC

Andrew Jennings
Corporate Controller
Egalet

Brian Jobe
Partner
Deloitte & Touche LLP

Timothy Kocses
Director, Corporate Technical Accounting
Bristol-Myers Squibb

David Lansky, PhD
President and CEO
Pacific Business Group on Health

Peter Licata
Chief Financial Officer
Edenbridge Pharmaceuticals, LLC

Mike Lombardo
Partner
Deloitte & Touche LLP

Kevin MacKay
Vice President, Global Technical Accounting
Advisory Services and Policies
Pfizer Inc

Mike Makovec
Audit Senior Manager
Deloitte & Touche LLP

Sal Mannarino
Senior Manager, Transaction Advisory Services
Ernst & Young LLP

Mark Merritt
President and CEO
PCMA

Peter J. Micca
US Audit & Assurance Health Tech Leader
Deloitte & Touche LLP

Jeffrey Miller
Senior Director, Commercial Operations Revenue Management
Impax Laboratories

Alasdair Milton, PhD
Vice President, Life Sciences — Parthenon
Ernst & Young LLP

Karim Munir
Director, Consolidations and Financial Reporting
Bristol-Myers Squibb

Federica “Freddi” O’Brien
Chief Financial Officer
Cerecor

Robert Owens
Vice President and Head of Accounting
Bristol-Myers Squibb

Frank Panaro
Director, Finance Gross to Net
Purdue Pharma L.P.

Christopher Park
Partner
Deloitte & Touche LLP

Sunil Patel
Vice President and Head of Corporate Development
Merck

Patrick D. Pilch, CPA, MBA
Managing Director and National Healthcare Leader
BDO Center for Healthcare Excellence & Innovation

Michael Pine
Vice President, Corporate Development and Licensing
Aralez Pharma

Graham Poles
Partner
PwC

Jim Quinlan
Partner
CFGI

Ravi Raghunathan, CPA
Partner - Life Sciences Industry Leader
CohnReznick LLP

Bryan Reasons
Chief Financial Officer
Impax Labs

Joe Reilly
Executive Director and Controller USP
Bristol-Myers Squibb

Derek Riesenberg
Vice President, Life Sciences — Parthenon
Ernst & Young LLP

Stephen Rivera
Vice President, Global Technical Accounting Advisory Services & Policy
Johnson & Johnson

William Roberts
Partner
Ernst & Young LLP

Laura Robinette
U.S. Pharmaceutical and Life Sciences Assurance Leader
PwC

James Rosenberg
Senior Assistant Chief Accountant, Office of Health Care and Insurance
U.S. Securities & Exchange Commission

Jessica Alysse Rubin, CPA
Executive Director, Finance and Assistant Controller
Acorda Therapeutics

Francis Ruffy
Director, Advisory Services
PwC

Bruce Rucks
Partner
Deloitte & Touche LLP

Maya Said, ScD
Founder and CEO
Outcomes4Me

Chris Santucci
Director
PwC

Brad Schulte
Senior Manager
Deloitte & Touche LLP

Jennifer Sharpe
Senior Director, Revenue Analytics Collaborative
daVIZta Inc., a Revenue Analytics Company

Michael Shultz
Director, Finance Transformation
BlackLine

Leigh Anne Siino
Director, Consulting Services
CGI

Robert P. Silvers
Partner, Litigation Department
Paul Hastings

Tedd Smith
Managing Director — Investment Banking
Morgan Stanley

Julie Song
Vice President, Chief Compliance Officer,
Ethics and Compliance Office
IQVIA

Corey Sparks
Executive Director, Controller & SBLO
Eisai Inc.

Nancy Stempin
Executive Director, Financial Accounting Advisory Services
Ernst & Young LLP

Jeffrey Stoll, PhD
Managing Director, Life Sciences – Parthenon
Ernst & Young LLP

Sagar Teotia
Deputy Chief Accountant
U.S. Securities & Exchange Commission

Erica Vandell
Director
The Siegfried Group, LLP

Scott Walters
Partner, Transaction Tax
Ernst & Young LLP

Michael Webster
Director, Technology & Management Consulting
RSM US LLP

Zachary Weisbly
Senior Manager
PwC

Walt Worsham
Senior Manager
Deloitte & Touche LLP